Intranasally administered muse cells attenuate neurodegeneration in Parkinson’s disease
Zhe Lu, Shifeng Ren, Bingjie Wang, Liwei Shao, Yajun Zhang, Haomeng Wu, Xiaodong Mu, Zhihui Wang · 2025
Read Intranasally administered muse cells attenuate neurodegeneration in Parkinson’s disease by Zhe Lu, Shifeng Ren, Bingjie Wang, Liwei Shao, Yajun Zhang, Haomeng Wu, Xiaodong Mu, Zhihui Wang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729229.txt.
Description
Zhe Lu and seven co-authors deliver stem cells through the nose in a Parkinson's study from two thousand twenty-five. The disease kills dopamine neurons deep in the brain, behind a barrier most cells cannot cross. Muse cells, a hardy stem cell type, home to damage unusually well.
In a lab barrier model, an inflammatory signal raised a lipid cue that loosened the barrier and let muse cells through. In mice modeling Parkinson's, nose-delivered muse cells reached the brain better than ordinary stem cells. Once there, they could turn into cells bearing the key dopamine enzyme. The authors present the nose route and the homing signal as a delivery strategy worth developing. Human work remains ahead.
Catalog record
| CREATOR | Zhe Lu, Shifeng Ren, Bingjie Wang, Liwei Shao, Yajun Zhang, Haomeng Wu, Xiaodong Mu, Zhihui Wang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |